Voyager Acquisition Corp. has announced an update to its previously disclosed Business Combination Agreement with Veraxa Biotech AG, initially announced in April 2025. According to a recent filing, Voyager has entered into a Joinder Agreement with Veraxa, PubCo, and Veraxa Cayman Merger Sub. This agreement integrates PubCo and Merger Sub into the original business combination deal, ensuring they are fully bound by its terms. The Joinder Agreement also outlines the process for transferring assets and liabilities to Merger Sub and the subsequent contribution of Merger Sub shares to PubCo. Additionally, it confirms the ownership structure and management of PubCo and Merger Sub as of the agreement's date.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。